Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00514072 | Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer | unknown | Phase 2 | 54 | Kael-GemVax Co., Ltd.INDUSTRY | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00676780 | Green Tea Extract and Prostate Cancer | completed | Phase 2 | 33 | Louisiana State University Health Sciences Center ShreveportOTHER | 1 | Aug 8, 2012 | clinicaltrials |
| NCT00038168 |
| Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma |
| completed |
| Phase 1 / Phase 2 |
| 14 |
| M.D. Anderson Cancer CenterOTHER |
| 1 |
| Aug 1, 2012 |
| clinicaltrials |
| NCT00512096 | Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis | completed | Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00003084 | Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer | completed | Phase 2 | 75 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00080808 | Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer | completed | Phase 2 | 111 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00811031 | Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC) | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 30, 2012 | clinicaltrials |
| NCT00027781 | MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 2 | 37 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Jul 24, 2012 | clinicaltrials |
| NCT01296243 | Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer | unknown | Phase 2 | 57 | Genta IncorporatedINDUSTRY | 1 | Jul 24, 2012 | clinicaltrials |
| NCT00058266 | Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy | terminated | Phase 2 | 36 | Northwestern UniversityOTHER | 1 | Jul 19, 2012 | clinicaltrials |
| NCT00471718 | ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | terminated | Phase 1 / Phase 2 | 27 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 11, 2012 | clinicaltrials |
| NCT00002903 | Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer | completed | Phase 2 | 25 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Jul 2, 2012 | clinicaltrials |
| NCT01630967 | Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC) | unknown | Phase 2 | 40 | British Columbia Cancer AgencyOTHER | 1 | Jun 28, 2012 | clinicaltrials |
| NCT00127387 | Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia | terminated | Phase 2 / Phase 3 | 54 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jun 26, 2012 | clinicaltrials |
| NCT00881725 | A Study of Pre-operative Metformin in Prostate Cancer(ANIMATE) | terminated | Phase 2 | 24 | University Health Network, TorontoOTHER | 1 | Jun 19, 2012 | clinicaltrials |
| NCT00186420 | Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation | completed | Phase 2 | 13 | Stanford UniversityOTHER | 1 | Jun 13, 2012 | clinicaltrials |
| NCT00309439 | ALA and Prostate Cancer | unknown | Phase 2 | — | University of TorontoOTHER | 0 | Jun 13, 2012 | clinicaltrials |
| NCT00048659 | YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy | terminated | Phase 2 | — | Astellas Pharma IncINDUSTRY | 10 | Jun 7, 2012 | clinicaltrials |
| NCT00050297 | YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer | terminated | Phase 2 | — | Astellas Pharma IncINDUSTRY | 7 | Jun 7, 2012 | clinicaltrials |
| NCT00257478 | A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy | completed | Phase 2 | — | Astellas Pharma IncINDUSTRY | 3 | Jun 7, 2012 | clinicaltrials |
| NCT00075192 | CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer | completed | Phase 1 / Phase 2 | 8 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00242931 | Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy | withdrawn | Phase 2 | 0 | OHSU Knight Cancer InstituteOTHER | 0 | Jun 1, 2012 | clinicaltrials |
| NCT00244920 | Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer | withdrawn | Phase 2 | 0 | OHSU Knight Cancer InstituteOTHER | 0 | May 28, 2012 | clinicaltrials |
| NCT00073970 | Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy | terminated | Phase 2 | 37 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 23, 2012 | clinicaltrials |
| NCT00004045 | Chemotherapy in Treating Patients With Prostate Cancer | completed | Phase 2 | — | Daiichi SankyoINDUSTRY | 1 | May 16, 2012 | clinicaltrials |
| NCT00031889 | Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer | completed | Phase 2 | 5 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00040365 | Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2012 | clinicaltrials |
| NCT01220817 | Safety and Efficacy of POMx Capsules in Men With Recurrent Prostate Cancer: An 18-Month Study | completed | Phase 2 | 104 | POM Wonderful LLCINDUSTRY | 1 | Apr 6, 2012 | clinicaltrials |
| NCT00558363 | ARTS - AVODART After Radical Therapy For Prostate Cancer Study(ARTS) | completed | Phase 2 | 294 | GlaxoSmithKlineINDUSTRY | 9 | Mar 21, 2012 | clinicaltrials |
| NCT00653757 | Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer | completed | Phase 1 / Phase 2 | 100 | Mayo ClinicOTHER | 1 | Mar 19, 2012 | clinicaltrials |
| NCT00731848 | Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate Cancer | unknown | Phase 2 | 30 | Roll International CorporationINDUSTRY | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00732043 | Extension to Study of Effects of Pomegranate Extract on Rising PSA Levels After Primary Therapy for Prostate Cancer | unknown | Phase 2 | 200 | Roll International CorporationINDUSTRY | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00083005 | Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate | completed | Phase 2 | 60 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT01340599 | Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery | terminated | Phase 2 | 5 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00064311 | Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00003643 | Combination Chemotherapy in Treating Men With Germ Cell Cancer | unknown | Phase 2 / Phase 3 | 498 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Mar 6, 2012 | clinicaltrials |
| NCT01132599 | Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer | withdrawn | Phase 2 | 0 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT00242918 | Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate Cancer | completed | Phase 2 | 29 | Benaroya Research InstituteOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00736164 | Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer | withdrawn | Phase 2 | 0 | Roswell Park Cancer InstituteOTHER | 0 | Feb 6, 2012 | clinicaltrials |
| NCT01132404 | Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448 | terminated | Phase 1 / Phase 2 | 9 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jan 31, 2012 | clinicaltrials |
| NCT00126165 | Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer | completed | Phase 1 / Phase 2 | 72 | Alberta Health servicesOTHER | 1 | Jan 19, 2012 | clinicaltrials |
| NCT00116779 | A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer | completed | Phase 2 | 127 | Ferring PharmaceuticalsINDUSTRY | 2 | Dec 19, 2011 | clinicaltrials |
| NCT01487902 | The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer | unknown | Phase 2 | 90 | Asan Medical CenterOTHER | 1 | Dec 8, 2011 | clinicaltrials |
| NCT00550810 | Sutent Maintenance After Response to Taxotere(SMART) | unknown | Phase 2 | 30 | Alberta Health servicesOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT01153113 | Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines | withdrawn | Phase 1 / Phase 2 | 0 | University of FloridaOTHER | 0 | Dec 2, 2011 | clinicaltrials |
| NCT00003887 | Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Nov 30, 2011 | clinicaltrials |
| NCT00973882 | Carboplatin-Etoposide Combination in Hormone-Resistant Prostate Cancers | completed | Phase 2 | 60 | Centre Leon BerardOTHER | 1 | Nov 3, 2011 | clinicaltrials |
| NCT00031187 | Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer | completed | Phase 2 | 160 | Seagen Inc.INDUSTRY | 1 | Oct 24, 2011 | clinicaltrials |
| NCT00005857 | Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy | completed | Phase 2 | — | City of Hope Medical CenterOTHER | 1 | Oct 20, 2011 | clinicaltrials |
| NCT00036075 | Study Using CP-461 to Treat Advanced Prostate Cancer | completed | Phase 2 | 25 | Astellas Pharma IncINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Aug 9, 2012source: clinicaltrials